[Should we modify hemoglobin targets in CKD patients? FDA and EMEA statements].
Martín de Francisco
A L
AL
Aljama
P
P
Arias
M
M
Górriz
J L
JL
Martínez Castelao
A
A
Portolés
J
J
D000740:Anemia / Q000097:blood / Q000209:etiology / Q000628:therapy; D002908:Chronic Disease; D005060:Europe; D006454:Hemoglobins / Q000032:analysis*; D006801:Humans; D007674:Kidney Diseases / Q000097:blood* / Q000150:complications / Q000628:therapy; D009938:Organizations; D014481:United States; D014486:United States Food and Drug Administration
D006454:Hemoglobins